Kymera Perspectives

Hear from our team on recent breakthroughs, scientific and clinical advancements, company culture, and our ongoing work to develop new medicines at Kymera.

Kymera_Images_Carousel_Sanofi-Spotlight
November 28, 2023

Partner Spotlight: Kymera and Sanofi chase “undruggable” targets in immunology

In 2020, Sanofi announced its partnership with Kymera Therapeutics, combining Sanofi’s resources and industry experience with the emerging biotech’s expertise in targeted protein degradation (TPD) aiming to create new options for patients struggling with immunological and inflammatory (I&I) conditions.

View Perspective

Featured

Headshot of Karen Weisbach
March 31, 2023
Driving Culture Through Values
Karen Weisbach, PHR, Head of People + Culture
See More
Headshot of Juliet Williams
March 1, 2023
Living Our Core Values – Pioneer: Breaking new ground with a powerful new modality
Juliet Williams, PhD, Head of Research
See More
Headshot of Brian Albarran
April 21, 2023
Small Molecules, Big Impact: Expanding the Universe of Targets
Brian Albarran, PhD, Senior Vice President, Head of Corporate Strategy
See More
Icon_In-the-News
Discover Our Latest Milestones

Stay ahead with the latest news from Kymera. Our Press Releases provide insights into our recent achievements and future endeavors.

  • Area of Focus

Related Stories